市場調查報告書

體外診斷 - 全球市場預測(2018年∼2027年)

In Vitro Diagnostics - Global Market Outlook (2018-2027)

出版商 Stratistics Market Research Consulting 商品編碼 932651
出版日期 內容資訊 英文 187 Pages
商品交期: 2-3個工作天內
價格
體外診斷 - 全球市場預測(2018年∼2027年) In Vitro Diagnostics - Global Market Outlook (2018-2027)
出版日期: 2020年03月01日內容資訊: 英文 187 Pages
簡介

體外診斷的全球市場,預計2018年達到879億3,000萬美元,從2018年到2027年預測將以7.2%的年複合成長率成長,2027年將達到1644億美元的規模。在實驗室的完全自動化設備的採用增加,個人化醫療意識高漲,及慢性疾病的成長,成為帶動市場成長的主要原因。但,不利的償付方案,抑制著市場成長。

體外診斷(IVD),從人體採取檢體治癒疾病和後遺症,對各種生物樣品實施體外檢驗,由查出所有種類的感染和疾病所使用的醫療設備與消耗品構成。這些產品,是設備、試劑,以及疾病診斷所使用的系統用於診斷各種疾病,例如糖尿病和癌症。

本報告提供全球體外診斷市場的相關調查,市場機會和威脅,成長及阻礙因素,各效用、產品、技術、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 簡介

第3章 市場趨勢分析

  • 簡介
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 產品分析
  • 科技分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

  • 供應商談判力
  • 買主談判力
  • 替代品的威脅
  • 新加入廠商的威脅
  • 競爭對手

第5章 全球體外診斷市場:效用

  • 簡介
  • 可重覆使用IVD設備
  • 拋棄式IVD設備

第6章 全球體外診斷市場:各產品

  • 簡介
  • 資料管理軟體
  • 試劑和套件
  • 服務
  • 設備
    • 半自動設備
    • 完全自動化設備

第7章 全球體外診斷市場:各技術

  • 簡介
  • 血液檢驗
  • 凝固與止血
  • 血液學
  • 免疫血液學
  • 微生物學
  • 組織診斷
  • 尿液檢查
  • 臨床化學
    • 基本的代謝面板
    • 電解質面板
    • 脂質簡介
    • 肝臟面板
    • 腎臟簡介
    • 特殊化學實驗
    • 甲狀腺功能面板
  • 分子診斷
    • DNA序列&下一代序列
    • 恆溫核酸增幅技術(INAAT)
    • 微陣列
    • 聚合酵素鏈鎖反應(PCR)
    • 雜合反應
  • 免疫測量/免疫化學
    • 酵素結合免疫斑點測定
    • 無線電免疫測量
    • 迅速檢驗
    • 西方印漬術
    • 酵素免疫分析法

第8章 全球體外診斷市場:各用途

  • 簡介
  • 自體免疫疾病
  • 循環系統
  • 糖尿病
  • 藥物檢驗/藥理基因學
  • 內分泌學
  • 消化器官疾病
  • HIV /愛滋病
  • 感染疾病
  • 腎臟學
  • 非感染疾病
  • 腫瘤學

第9章 全球體外診斷市場:終端用戶

  • 簡介
  • 學術機構
  • 居家護理
  • 醫院
  • 患者的自診斷
  • 照護現場試驗
  • 研究所
    • 大規模/ 索引實驗室
    • 中規模研究所
    • 小研究所

第10章 全球體外診斷市場: 各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東、非洲地區
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和近東及非洲的其他中東的地區

第11章 主要發展

  • 契約,夥伴關係,合作,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第12章 企業簡介

  • Abbott Laboratories Inc
  • Agilent Technologies
  • Becton Dickinson and Company
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc
  • Cepheid
  • Danaher Corporation
  • Diasorin
  • Johnson & Johnson
  • Leica Biosystems Nussloch GmbH
  • Qiagen
  • Roche Diagnostics
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific
目錄

According to Stratistics MRC, the Global In Vitro Diagnostics Market is accounted for $87.93 billion in 2018 and is expected to reach $164.40 billion by 2027 growing at a CAGR of 7.2% during the forecast period. Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth. However, adverse reimbursement scenario is restraining the market growth.

In Vitro Diagnostics (IVD) consists of medical devices and consumables that are utilized to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae and perform in vitro tests on various biological samples. These products can be instruments, reagents, or any system used for the diagnosis of diseases. They are used for the diagnosis of various medical conditions, such as diabetes and cancer.

Based on end user, the point-of-care testing segment is likely to have a huge demand due rising requirements of these testing's as it includes biosensors, pregnancy kits and glucose meters to ensure quick and accurate results. By geography, North America is going to have a lucrative growth during the forecast period due to awareness among people regarding availability of innovative products and upsurge of strong prominent business players will lead to market growth.

Some of the key players profiled in the In Vitro Diagnostics Market include Abbott Laboratories Inc, Agilent Technologies, Becton Dickinson and Company, Biomerieux Sa, Bio-Rad Laboratories Inc, Cepheid, Danaher Corporation, Diasorin, Johnson & Johnson, Leica Biosystems Nussloch GmbH, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific.

Usability's Covered:

  • Reusable IVD Devices
  • Disposable IVD Devices

Products Covered:

  • Data Management Software
  • Reagents & Kits
  • Services
  • Instruments

Technologies Covered:

  • Blood Testing
  • Coagulation and Hemostasis
  • Hematology
  • Immunohematology
  • Microbiology
  • Tissue Diagnostics
  • Urinalysis
  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunoassay/Immunochemistry

Applications Covered:

  • Autoimmune Diseases
  • Cardiology
  • Diabetes
  • Drug Testing/Pharmacogenomics
  • Endocrinology
  • Gastrointestinal Diseases
  • HIV/Aids
  • Infectious Diseases
  • Nephrology
  • Non Infectious Diseases
  • Oncology

End Users Covered:

  • Academic Institutes
  • Home Care
  • Hospitals
  • Patient Self-Testing
  • Point-Of-Care Testing
  • Laboratories

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global In Vitro Diagnostics Market, By Usability

  • 5.1 Introduction
  • 5.2 Reusable IVD Devices
  • 5.3 Disposable IVD Devices

6 Global In Vitro Diagnostics Market, By Product

  • 6.1 Introduction
  • 6.2 Data Management Software
  • 6.3 Reagents & Kits
  • 6.4 Services
  • 6.5 Instruments
    • 6.5.1 Semi-Automated Instruments
    • 6.5.2 Fully Automated Instruments

7 Global In Vitro Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Blood Testing
  • 7.3 Coagulation and Hemostasis
  • 7.4 Hematology
  • 7.5 Immunohematology
  • 7.6 Microbiology
  • 7.7 Tissue Diagnostics
  • 7.8 Urinalysis
  • 7.9 Clinical Chemistry
    • 7.9.1 Basic Metabolic Panel
    • 7.9.2 Electrolyte Panel
    • 7.9.3 Lipid Profile
    • 7.9.4 Liver Panel
    • 7.9.5 Renal Profile
    • 7.9.6 Specialty Chemical Tests
    • 7.9.7 Thyroid Function Panel
  • 7.10 Molecular Diagnostics
    • 7.10.1 Dna Sequencing & Next-Generation Sequencing
    • 7.10.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.10.3 Microarray
    • 7.10.4 Polymerase Chain Reaction (PCR)
    • 7.10.5 Hybridization
      • 7.10.5.1 In-Situ Hybridization
      • 7.10.5.2 Fluorescence In-Situ Hybridization
  • 7.11 Immunoassay/Immunochemistry
    • 7.11.1 Enzyme-Linked Immunospot Assays
    • 7.11.2 Radioimmunoassay
    • 7.11.3 Rapid Test
    • 7.11.4 Western Blotting
    • 7.11.5 Enzyme-Linked Immunosorbent Assay
      • 7.11.5.1 Chemiluminescence Immunoassays
      • 7.11.5.2 Colorimetric Immunoassays
      • 7.11.5.3 Fluorescence Immunoassays

8 Global In Vitro Diagnostics Market, By Application

  • 8.1 Introduction
  • 8.2 Autoimmune Diseases
  • 8.3 Cardiology
  • 8.4 Diabetes
  • 8.5 Drug Testing/Pharmacogenomics
  • 8.6 Endocrinology
  • 8.7 Gastrointestinal Diseases
  • 8.8 HIV/Aids
  • 8.9 Infectious Diseases
  • 8.10 Nephrology
  • 8.11 Non Infectious Diseases
  • 8.12 Oncology

9 Global In Vitro Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Academic Institutes
  • 9.3 Home Care
  • 9.4 Hospitals
  • 9.5 Patient Self-Testing
  • 9.6 Point-Of-Care Testing
  • 9.7 Laboratories
    • 9.7.1 Large/Reference Laboratories
    • 9.7.2 Medium-Sized Laboratories
    • 9.7.3 Small Laboratories

10 Global In Vitro Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories Inc
  • 12.2 Agilent Technologies
  • 12.3 Becton Dickinson and Company
  • 12.4 Biomerieux Sa
  • 12.5 Bio-Rad Laboratories Inc
  • 12.6 Cepheid
  • 12.7 Danaher Corporation
  • 12.8 Diasorin
  • 12.9 Johnson & Johnson
  • 12.10 Leica Biosystems Nussloch GmbH
  • 12.11 Qiagen
  • 12.12 Roche Diagnostics
  • 12.13 Siemens AG
  • 12.14 Sysmex Corporation
  • 12.15 Thermo Fisher Scientific

List of Tables

  • Table 1 Global In Vitro Diagnostics Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global In Vitro Diagnostics Market Outlook, By Usability (2017-2027) ($MN)
  • Table 3 Global In Vitro Diagnostics Market Outlook, By Reusable IVD Devices (2017-2027) ($MN)
  • Table 4 Global In Vitro Diagnostics Market Outlook, By Disposable IVD Devices (2017-2027) ($MN)
  • Table 5 Global In Vitro Diagnostics Market Outlook, By Product (2017-2027) ($MN)
  • Table 6 Global In Vitro Diagnostics Market Outlook, By Data Management Software (2017-2027) ($MN)
  • Table 7 Global In Vitro Diagnostics Market Outlook, By Reagents & Kits (2017-2027) ($MN)
  • Table 8 Global In Vitro Diagnostics Market Outlook, By Services (2017-2027) ($MN)
  • Table 9 Global In Vitro Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
  • Table 10 Global In Vitro Diagnostics Market Outlook, By Semi-Automated Instruments (2017-2027) ($MN)
  • Table 11 Global In Vitro Diagnostics Market Outlook, By Fully Automated Instruments (2017-2027) ($MN)
  • Table 12 Global In Vitro Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
  • Table 13 Global In Vitro Diagnostics Market Outlook, By Blood Testing (2017-2027) ($MN)
  • Table 14 Global In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2017-2027) ($MN)
  • Table 15 Global In Vitro Diagnostics Market Outlook, By Hematology (2017-2027) ($MN)
  • Table 16 Global In Vitro Diagnostics Market Outlook, By Immunohematology (2017-2027) ($MN)
  • Table 17 Global In Vitro Diagnostics Market Outlook, By Microbiology (2017-2027) ($MN)
  • Table 18 Global In Vitro Diagnostics Market Outlook, By Tissue Diagnostics (2017-2027) ($MN)
  • Table 19 Global In Vitro Diagnostics Market Outlook, By Urinalysis (2017-2027) ($MN)
  • Table 20 Global In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2017-2027) ($MN)
  • Table 21 Global In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2017-2027) ($MN)
  • Table 22 Global In Vitro Diagnostics Market Outlook, By Electrolyte Panel (2017-2027) ($MN)
  • Table 23 Global In Vitro Diagnostics Market Outlook, By Lipid Profile (2017-2027) ($MN)
  • Table 24 Global In Vitro Diagnostics Market Outlook, By Liver Panel (2017-2027) ($MN)
  • Table 25 Global In Vitro Diagnostics Market Outlook, By Renal Profile (2017-2027) ($MN)
  • Table 26 Global In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2017-2027) ($MN)
  • Table 27 Global In Vitro Diagnostics Market Outlook, By Thyroid Function Panel (2017-2027) ($MN)
  • Table 28 Global In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (2017-2027) ($MN)
  • Table 29 Global In Vitro Diagnostics Market Outlook, By Dna Sequencing & Next-Generation Sequencing (2017-2027) ($MN)
  • Table 30 Global In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
  • Table 31 Global In Vitro Diagnostics Market Outlook, By Microarray (2017-2027) ($MN)
  • Table 32 Global In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
  • Table 33 Global In Vitro Diagnostics Market Outlook, By Hybridization (2017-2027) ($MN)
  • Table 34 Global In Vitro Diagnostics Market Outlook, By Immunoassay/Immunochemistry (2017-2027) ($MN)
  • Table 35 Global In Vitro Diagnostics Market Outlook, By Enzyme-Linked Immunospot Assays (2017-2027) ($MN)
  • Table 36 Global In Vitro Diagnostics Market Outlook, By Radioimmunoassay (2017-2027) ($MN)
  • Table 37 Global In Vitro Diagnostics Market Outlook, By Rapid Test (2017-2027) ($MN)
  • Table 38 Global In Vitro Diagnostics Market Outlook, By Western Blotting (2017-2027) ($MN)
  • Table 39 Global In Vitro Diagnostics Market Outlook, By Enzyme-Linked Immunosorbent Assay (2017-2027) ($MN)
  • Table 40 Global In Vitro Diagnostics Market Outlook, By Application (2017-2027) ($MN)
  • Table 41 Global In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2017-2027) ($MN)
  • Table 42 Global In Vitro Diagnostics Market Outlook, By Cardiology (2017-2027) ($MN)
  • Table 43 Global In Vitro Diagnostics Market Outlook, By Diabetes (2017-2027) ($MN)
  • Table 44 Global In Vitro Diagnostics Market Outlook, By Drug Testing/Pharmacogenomics (2017-2027) ($MN)
  • Table 45 Global In Vitro Diagnostics Market Outlook, By Endocrinology (2017-2027) ($MN)
  • Table 46 Global In Vitro Diagnostics Market Outlook, By Gastrointestinal Diseases (2017-2027) ($MN)
  • Table 47 Global In Vitro Diagnostics Market Outlook, By HIV/Aids (2017-2027) ($MN)
  • Table 48 Global In Vitro Diagnostics Market Outlook, By Infectious Diseases (2017-2027) ($MN)
  • Table 49 Global In Vitro Diagnostics Market Outlook, By Nephrology (2017-2027) ($MN)
  • Table 50 Global In Vitro Diagnostics Market Outlook, By Non Infectious Diseases (2017-2027) ($MN)
  • Table 51 Global In Vitro Diagnostics Market Outlook, By Oncology (2017-2027) ($MN)
  • Table 52 Global In Vitro Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 53 Global In Vitro Diagnostics Market Outlook, By Academic Institutes (2017-2027) ($MN)
  • Table 54 Global In Vitro Diagnostics Market Outlook, By Home Care (2017-2027) ($MN)
  • Table 55 Global In Vitro Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 56 Global In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2017-2027) ($MN)
  • Table 57 Global In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2017-2027) ($MN)
  • Table 58 Global In Vitro Diagnostics Market Outlook, By Laboratories (2017-2027) ($MN)
  • Table 59 Global In Vitro Diagnostics Market Outlook, By Large/Reference Laboratories (2017-2027) ($MN)
  • Table 60 Global In Vitro Diagnostics Market Outlook, By Medium-Sized Laboratories (2017-2027) ($MN)
  • Table 61 Global In Vitro Diagnostics Market Outlook, By Small Laboratories (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.